# Lisdexamfetamine dimesylate

NDC: 70010-216
Generic name: Lisdexamfetamine dimesylate
Labeler / Manufacturer: Granules Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20241217

FDA application: ANDA219258

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70010-216"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70010-216
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56b4712-2fb8-4c7a-bfbd-0401d9f5f92a